Liaison(s): Aylene Bao, Kyle Mak, Andrew Mica
Amgen, Inc., a world class biopharmaceutical company, discovers, develops, manufactures and delivers therapeutic products for the disease areas of oncology, hematology, inflammation, bone health, nephrology and cardiovascular diseases. Since its founding in 1980, Amgen has grown rapidly to attain a market capitalization of $91 billion with a world-wide presence in over 50 countries. Amgen currently produces 12 products for 20 different disease indications while pursuing numerous additional drugs through Amgen R&D. Amgen is headquartered in Thousand Oaks, California and employs 20,000 staff worldwide. As Amgen’s network evolves and grows to supply more countries with more products, their supply chain will face increasing challenges in planning, sourcing, and delivery. As a result of this growth, Amgen has sought to evaluate optimal supply chain models to ensure time to market, outstanding patient supply and efficient delivery of its products across world markets. The Amgen Supply Chain TMP was asked to benchmark supply chain best practices across a number of selected industries. Model companies were chosen, by brainstorming with Amgen liaisons, from industries with high value products, stringent regulations, or highly efficient supply chain behaviors. The team gathered information about supply chain management and supply chain strategies for these prominent targeted companies in the pharmaceutical, biotechnology, diagnostic, consumer technology and e-commerce industries. From this research, the Amgen Supply Chain TMP identified best practices and common trends within and across these industries. After analyzing these industrial trends, the KGI team pursued two focus areas in the spring semester: global trade management and inventory management. Ultimately, the team performed an in-depth qualitative analysis of supply chain opportunities before making recommendations to Amgen regarding their use of new tools in global trade management and inventory management.